Human telomeric repeat binding factors TRF1, TRF2 along with TIN2 form a core of shelterin complex that protects chromosome ends against unwanted end-joining and DNA repair. We applied a singlemolecule approach to assess TRF1-TIN2-TRF2 complex formation in solution at physiological conditions. Fluorescence Cross-Correlation Spectroscopy (FCCS) was used to describe the complex formation by analyzing how coincident fluctuations of differently labeled TRF1 and TRF2 correlate when they move together through the confocal volume of the microscope. We observed, at the singlemolecule level, that TRF1 effectively substituted TRF2 on TIN2. We assessed the effect of another telomeric factor TPP1 that recruits telomerase to telomeres. We found that TPP1 upon binding to TIN2 induces allosteric changes that expand TIN2 binding capacity, such that TIN2 can accommodate both TRF1 and TRF2 simultaneously. We suggest a molecular model that explains why TPP1 is essential for the stable formation of TRF1-TIN2-TRF2 core complex. Janovic et al. TRF1 replaces TRF2 on TIN2 when TPP1 is absent 2
Introduction
Human telomeres are maintained by telomerase 1, 2 and protected by telomeric proteins 3, 4 . Telomeric proteins recruit telomerase to telomeric DNA 5 . Shelterin is a six-protein complex comprising of TRF1, TRF2, TIN2, TPP1, POT1 and RAP1. Shelterin associates specifically with telomeric DNA repeats and protects linear chromosome ends from being recognized by the DNA repair machinery as damaged DNA 4 . TRF1 and TRF2 bind the double-stranded telomeric DNA 6, 7 . TRF2 protects chromosome ends mainly by invasion of the 3' single-stranded overhang into the duplex telomeric repeats, thus forming protective lasso-like structures known as telomeric loops 8, 9 . RAP1 interacts solely with TRF2 and regulates specificity of TRF2's binding to telomeric DNA and subsequent telomeric loop processing by helicases 10, 11 .
TIN2 (TRF1-Interacting Nuclear factor 2) 12 binds both factors, TRF1 and TRF2 (Telomere Repeatbinding Factor 1 and 2) 4 . In addition, TIN2 recruits TPP1 (encoded by the gene ACD) that forms a heterodimer with POT1 (Protection of Telomeres 1) 13 . From the structural point of view, TIN2 is the central hub of the shelterin complex that links TRF1 and TRF2 homodimers with TPP1-POT1
heterodimer. Interaction domains of TIN2 that take part in TRF1, TRF2 and TPP1 binding are shown in Figure 1a .
[Please place Figure 1 here, single-column space]
Regarding biological functions, TIN2 is essential for telomere length regulation mediated by TRF1 14, 15 .
TIN2 is required for TRF2-induced protection against ATM signaling pathway 16 and POT1-meditated protection against ATR signaling pathway 17, 18 . TIN2 deletion compromises the stability of both TRF1 and TRF2 at telomeres in cells 12, 19 . TIN2 bridges TRF1 and TRF2 with TPP1 that recruits telomerase to telomeres 5, 20 and enhances telomerase processivity upon complexation with POT1 [21] [22] [23] . The assembly of shelterin subunits around TIN2 is critical for the formation of structurally and biologically functional shelterin complex. Mutations in the gene of TIN2 have been implicated in approximately 15% of all known cases of dyskarotis congenita -a disease that results in defective telomere maintenance of adults 24, 25 . Thus, the shelterin assembly mechanism and the stoichiometry of associated proteins are in the center of interest of telomere research community.
The overall shelterin stoichiometry on telomeres is known in vivo 26 . Newly, the in vitro stoichiometry of an assembled core complex comprising TRF2, TIN2, TPP1, and POT1 was revealed to be 2:1:1:1, respectively 27 . Previous studies described the structure and binding affinity of peptides representing interaction regions that take part in TRF1 and TRF2 binding to TIN2 28 . Very recently, the structure of the isolated interacting domains of TRF2, TIN2 and TPP1 has been determined 29 .
On the contrary, very little is known about how full-length TRF1 and TPP1 affect other full-length shelterin proteins during their assembly. The quantitative studies of shelterin proteins moving freely in solution represent an experimental challenge connected with the comparable size of TRF1 and TRF2 that excludes using simple fluorescence polarization measurements. Recently more extensively introduced single-molecule approaches are powerful tools of assessing the functional states of a molecular system as has been demonstrated by assessing DNA-repair complex assembly and dynamics 30, 31 .
To reveal the structure, assembly and function of telomeric proteins and telomerase, single-molecule approaches could be applied as carefully reviewed by Parks and Stone 32 . However, classical TIRF (Total Internal Reflection Fluorescence) microscopy based single-molecule approaches are often limited to the area near the surface, as studied molecules are attached to the surface. On the other hand, if we use confocal scanning microscopy, we can measure interactions of fluorescently labeled proteins moving freely in solution regardless of the distance from the surface.
In this study, we took advantage of Fluorescence Cross-Correlation Spectroscopy (FCCS) -a singlemolecule method that is based on an evaluation of the interdependence of time-resolved fluctuations of two different fluorophores by confocal microscopy 33 . FCCS monitors simultaneous fluorescence signals of two differently labeled proteins that diffuse through the confocal volume of a microscope objective ( Figure 1b) 34, 35 . FCCS has previously been extensively used to describe assembly of oligomeric calcium/CaM-dependent kinase II and calmodulin by the Schwille laboratory 33 .
We used FCCS to monitor protein binding based on the change in relative cross-correlation of differently labeled TIN2, TRF1 and TRF2 in vitro and to address the following hypotheses.
First, we wanted to know whether both TRF1 and TRF2 bind TIN2 simultaneously or if there is an order preference during the shelterin subcomplex assembly. Additionally, we tested the hypothesis that TPP1 binding to TIN2 may improve TRF2-TIN2 interaction and could enable TIN2 to interact simultaneously with TRF1 and TRF2 as has been suggested by the Songyang laboratory 36 . Finally, we wondered if we could suggest an interaction model of TRF1, TRF2, TIN2, and TPP1 assembly and correlate the model with available structural data and biological functions of shelterin proteins.
We found that TRF1 induces TRF2 release from TIN2. We also described that TPP1, upon binding to TIN2, improves TIN2's binding capacity so the complex TIN2-TPP1 can accommodate both TRF1 and TRF2. Thus, we confirmed, at the single-molecule level, that TPP1 is essential for the formation of the stable TRF1-TIN2-TPP1-TRF2 complex. We suggest a mechanism that explains the exclusivity of TRF1-TIN2 interaction along with the requirement of TPP1 for simultaneous binding of TRF1 and TRF2 to TIN2. This work is, to our knowledge, the first single-molecule study describing full-length proteins TRF1, TRF2 and TIN2 during shelterin assembly in solution. The application of new experimental approaches enabled us to describe how the arrangement and structure of functional subcomplexes contribute to the role of complete shelterin in telomere protection.
Results

TRF1 replaces TRF2 bound to TIN2
We wanted to know whether TIN2 can accommodate both TRF1 and TRF2 simultaneously. According to previous measurements of Hu et al. and Chen et al. 28, 29 along with our MST assays (Figure 2-figure supplement 2) we allowed to form stable complexes of TRF1-TIN2 and TRF2-TIN2 at micromolar concentrations. We prepared protein complexes in 2:1 stoichiometry for TRF1 or TRF2 and TIN2 according to Lim et al. 27 , in all experiments within this study. TRF1 or TRF2 (20 nM) labeled with red fluorophore Alexa Fluor 594 in complex with TIN2 (10nM) labeled with the green fluorophore Alexa Fluor 488 were used in our FCCS measurements.
In the first experiment, we titrated dual-labeled TRF2-TIN2 complex with unlabeled TRF1 to the final concentration 80 nM (Figure 2a ).
We observed that TRF1 decreased the relative cross-correlation between TIN2 and TRF2 immediately after TRF1 addition to total 2.5 nM concentration. The decrease of relative cross-correlation suggested that TRF1 replaced TRF2 in complex with TIN2 ( Figure 2a TRF2 has no effect on DNA binding affinity of TRF1-TIN2
We wanted to know whether the presence of full-length TRF2 affects TRF1 binding to telomeric DNA when TRF1 is in complex with TIN2. To analyze how mutual TRF1, TRF2 and TIN2 interactions affect DNA binding affinity, we employed fluorescence anisotropy (Figure 3) . For DNA binding studies describing affinity to telomeric duplex R5 comprising five telomeric repeats (for exact sequence of R5 see Materials and Methods), we used stoichiometric combination of TRF1, TRF2 and TIN2, 2:2:1, respectively, as has been suggested previously 26, 27 . R5 should feasibly accommodate both TRF1 and TRF2 simultaneously. Our quantitative binding data revealed that DNA binding affinity of the stoichiometric combination of TRF1, TRF2 and TIN2 is similar to DNA binding affinity of the combination TRF1 and TIN2. In other words, TRF2 did not affect DNA binding affinity of TRF1-TIN2.
[Please place Figure 3 is responsible for its binding to TIN2 and that TPP1 stabilizes TIN2-TRF2 interaction 29 . Recombinant human TPP1 with an N-terminal deletion, TPP1 (89-554), was used, as full-length TPP1 purity was insufficient for single-molecule experiments. TPP1 (89-554) was chosen because the 88 N-terminal residues of TPP1 are functionally dispensable in human cells and are not conserved among TPP1
proteins of different organisms 23, 37, 38 . Additionally, TPP1 (89-554) still contains N-terminus of OB domain that is critical for telomerase activity 39 . For simplicity, we hereafter use TPP1 to represent TPP1 (89-554) unless stated otherwise. We incubated fluorescently labeled TRF2 and TIN2 along with unlabeled TPP1 at room temperature. Then, we added unlabeled TRF1 to see whether TRF1 can still replace TRF2 from the TIN2-TPP1-TRF2 complex. As Figure 5 shows, relative cross-correlation between TRF2 and TIN2 remained at high levels for all concentrations of TRF1. The unchanged relative cross-correlation suggested that TRF2 remains bound to TIN2 in TRF1 and TPP1 presence. The formation of the complex TRF1-TIN2-TPP1-TRF2 was confirmed by a complementary FCCS experiment where TRF1 and TRF2 were labeled by Alexa Fluor 488 and Alexa Fluor 594, respectively. To confirm that proteins form a stable complex, we recorded size-exclusion chromatography profiles of mixture comprising TRF1, TIN2 and TRF2 with or without TPP1 (Figure 5d ). Only in presence of TPP1 we observed a high-molecular peak that corresponds to the assembled protein complex (compare the solid red line and dashed blue line in Figure 5d ). We analyzed collected chromatographic fractions by SDS gel electrophoresis. As TRF1 and TRF2 were labeled by different fluorophores, we identified electrophoretic bands corresponding to TRF1 and TRF2 in fluorescence densitograms (insets in Figure   5d ). The fluorescence intensity profiles showed that TRF1 and TRF2 formed a complex only if TPP1
and TIN2 were present.
Additionally, we have carried out control measurements with TIN2 mutants that were unable to bind TPP1 or TRF2 on the N--terminal part of TIN2. We have prepared two TIN2 point mutants -A15R and A110R. A15R mutation of TIN2 prevents TPP1 binding; A110R mutation of TIN2 prevents TRF2 binding to N-terminal binding site of TIN2, as revealed by Hu et al. 29 . FCCS studies showed that both mutations of TIN2 restricted the assembly of shelterin core complex ( In summary, our combined single-molecule and ensemble analyses of full-length shelterin core proteins supported the view that TPP1 enables TIN2 to bind both TRF1 and TRF2 together and form stable TRF1-TIN2-TPP1-TRF2 complex.
Discussion
Our findings of how human telomeric proteins TRF1 and TPP1 affect the formation of core shelterin complex TRF1-TIN2-TRF2 have provided new insights into the assembly of full shelterin complex at the single-molecule level. In addition, our study has contributed to address the following biological questions about human shelterin: suggested that TRF1-TIN2 and TRF2-TIN2 occur as separate sub-complexes based on immunoprecipitation studies 36 . Additionally, when we take into consideration available information about the positions of interacting domains, domain structure and quantitative binding characterizations, we can rationalize why TRF1 replaces TRF2 on TIN2. So far, it seems that shelterin proteins form heteromultimer complexes through a selective domain-domain-interaction mechanism.
As Chen et al. showed, both TRF2 and TRF1 can bind one common binding site TBM (TRFH-binding motif, Figure 1a ) on TIN2 28 . TBM at the C-terminus of TIN2 is a well-structured 256-276 region that interacts with TRFH domain of both TRF1 and TRF2. The surface of TBM matches better the hydrophobic interface of TRFH domain of TRF1 than the polar interface of TRFH domain of TRF2. The different structural arrangements of interaction interfaces prompt that TRFH domain of TRF1 binds a peptide representing the TBM region of TIN2 with higher binding affinity than the TRFH domain of TRF2 28 .
In addition, there is another well-structured binding site at TIN2's N-terminus (TRFH-like) where TRF2 binds with higher affinity compared to the previously mentioned common TRF1/TRF2 binding site TBM.
If we consider that interactions between proteins occur mainly through the minimal identified domains, we may expect similar binding affinity for full-length proteins. Thus, TRF1 may form a complex with TIN2 more readily than TRF2. The higher binding affinity of TRF1 to TIN2 causes higher preference for the formation of complex TRF1-TIN2 compared to TRF2-TIN2. The ensemble binding affinity of fulllength TRF1 to TIN2 with KD 240 nM and TRF2 to TIN2 with KD 360 nM have been measured by Microscale thermophoresis (Figure 2-figure supplement 2) . Here obtained higher binding affinities for full-length proteins than affinities for isolated domains measured by Chen et al. 28 and Hu et al. 29 might suggest that additional hydrophobic and hydration effects promote full-length protein interactions 40 .
If we consider that TRF1 and TRF2 concentrations are similar in vivo 26 , we suppose that TRF1-TIN2 complex incidence should prevail over TRF2-TIN2 complex occurrence significantly. Additionally, if there was no other binding site on TIN2 for TRF2 or a binding regulation mechanism, the probability of forming complex TRF1-TIN2-TRF2 would be negligible. The second binding site for TRF2 on TIN2 (TRFH-like domain, Figure 1a ) should allow tri-functional complex TRF1-TIN2-TRF2 formation.
In this context, our finding that TRF1 can substitute TRF2 when bound to TIN2 was rather unexpected at first glance (Figure 2a, c, e) . However, we can rationalize TRF2 displacement when we consider that TRF1 binding affinity to TIN2 is ten-fold higher 29 than TRF2 binding to TBM on TIN2 28 Why is TRF2 released upon TRF1 binding when there are two independent binding sites for TRF1 and TRF2? One straightforward explanation would be that TRF1 bound to TIN2 presents a steric hindrance that disturbs optimal interaction surface between TRF2 and TIN2. The second explanation could be that TRF1 induces allosteric changes in TRFH-like domain of TIN2 that disable TRF2 binding to TIN2.
Moreover, there could be a combination of both -structural restrictions and allosteric changes.
Nevertheless, TRF2 binding to TRF1-TIN2 has to be promoted to form the stable core complex TRF1-TIN2-TRF2. As TPP1 induces allosteric changes on TIN2 that enable TRF2 binding and increase TRF2 binding affinity, TPP1 acts as an assembly activator that is required for the stable formation of TRF1-TIN2-TPP1-TRF2 complex.
Our single-molecule FCCS results support the view that TPP1 acts as a shelterin assembly activator.
We corroborated that TRF2 remained bound to TIN2 in TRF1 presence and TRF1-TIN2-TRF2 complex was formed when TPP1 was bound to TIN2 (Figure 5a , Figure 5-figure supplement 1) . We summarize our recent results within the framework of the present state of knowledge of shelterin core assembly in the model below.
Model of core shelterin assembly
We propose a model of how shelterin core proteins assemble in solution. The model takes into consideration that TRF1 and TRF2 form homodimers 41, 42 , as the homodimerization exclusivity of TRF1
and TRF2 is a functional requirement that facilitates separation of different functions for the both TRF proteins of similar domain structure. The model also reflects the stoichiometry of shelterin proteins that has been revealed by the de Lange and the Cech laboratories 26, 27 .
The recommended model suggests that if TRF1 occupies the TBM binding site on TIN2, TRF2 binding to TIN2 is compromised and only TRF1 remains bound to TIN2 ( Figure 6 ). When TPP1 binds TIN2, TIN2 is allosterically changed and its N-terminal binding site becomes active. Then, TRF2 can bind TIN2 also in TRF1 presence. Thus, TPP1 activates the N-terminal binding site for TRF2 on TIN2 and enables TIN2 to accommodate both TRF1 and TRF2 simultaneously. The model suggests that the protein order during shelterin core self-assembly in solution is TRF1 > TIN2 > TPP1 > TRF2.
Additionally, the model explains the unique ability of TRF1 to exclude TRF2 from the complex TRF2-TIN2. Our model suggests that TRF1-TIN2 is an initial complex based on the highest affinity between TIN2 and TRF1 among shelterin proteins 28 . Moreover, TRF1-TIN2 preferential binding explains why it
is not possible to prepare TRF1-TIN2-TRF2 complex without TPP1. TPP1 must induce allosteric structural changes on TIN2 to open N-terminal TRF2 binding site 29 .
The induced structural changes allow tighter binding of TRF2 to TIN2 without the compromising effect of the prebound TRF1.
[Please place Figure 6 here, single-column space]
The proposed model suggests that TRF1 and TRF2 dimers are bound to TIN2 monomer. The equimolar TRF1:TRF2 ratio is in accordance with our size-exclusion chromatography analysis that showed the same fluorescence intensity of labeled TRF1 and labeled TRF2 in complex with TIN2 and TPP1 ( Figure   5d , red solid line). The equimolar ratio TRF1:TRF2 along with previous observation of the Cech laboratory that TRF2 forms complex with TIN2 in 2:1 stoichiometry 27 suggest that TRF1:TIN2 complex has 2:1 stoichiometry.
The model with two TRF2 binding sites on TIN2 has been supported by our FCCS experiments with mutated variants of TIN2 ( Figure 5-figure supplement 2) . We observed no cross-correlation for TIN2 mutants that were unable to bind TPP1 or TRF2 on N-terminus of TIN2. The point mutations of TIN2 prevented the complexation of TRF1 and TRF2. The model supports the view that the N-terminal binding domain of TIN2 is essential for the cooperative binding of TRF2 and TPP1 to TIN2 and promoting assembly of TRF1-TIN2-TRF2-TPP1 complex.
The proposed model is applicable also to mechanisms where proteins first form weak transient complexes, and then depend on the additive energies of binding and allosteric changes provided by partner proteins to generate higher specificity. Finally, the intrinsic dynamics of TRF1 and TRF2 could be important for regulating the assembly and disassembly of shelterin complexes and exchanging between capped and uncapped telomere structures 43 .
The question is how the suggested model of protein assembly corresponds to the situation when DNA appears in solution. We speculate that telomeric DNA could serve as a scaffold to which TRF1 and TRF2 bind with high affinity 11, 44 . Thus, DNA may promote the assembly of TIN2, TRF1 and TRF2 without TPP1. In cellular environment, the situation could be more intricate if telomeric DNA is folded to quadruplexes that might prevent binding TRF1 and TRF2. If DNA is in quadruplex form, POT1 has to be engaged to unfold quadruplexes 45 and allow formation of double-stranded regions and singlestranded junctions on telomeric DNA -TRF1 and TRF2 primary binding sites. As POT1 dimerizes with TPP1 readily 29, 46 and TPP1 contributes to higher affinity of POT1 to DNA 23 
Material and Methods
Cloning, expression and purification of TRF1, TRF2, TIN2 and TPP1
The cDNA sequences of TRF1, TRF2, TIN2, and TPP1 were synthesized by Source BioScience and cloned to pDONR/Zeo vector (Life Technologies) using two sets of primers and BP clonase enzyme 
DNA substrates
For the DNA binding affinity studies, DNA duplex R5 was prepared by annealing a fluorescently oligonucleotide (Alexa Fluor 488) with the sequence 5' -GTTAGGGTTAGGGTTAGGG TTAGGGTTAGGGTTAG -3', respectively and its complementary strand. The sequence of R5 was designed in accordance to the optimal binding site of TRF2 defined by the de Lange laboratory 47 . The substrate was purified using a Mono Q 5/50 GL column (GE Healthcare) with a gradient of 50-1000 mM LiCl in 25 mM Tris-HCl, pH 7.5. All oligonucleotides were purchased from Sigma-Aldrich.
Fluorescence anisotropy
Measurements of TRF1-TIN2 and TRF2-TIN2 binding to telomeric DNA duplex R5 labeled by Alexa
Fluor 488 were performed on a FluoroMax-4 spectrofluorometer (Horiba Jobin Yvon, Edison, NJ). All experiments were carried out at 25°C. Fluorescence anisotropy was monitored at an excitation wavelength of 490 nm and emission wavelength of 520 nm. The slit width (both excitation and emission)
for all measurements was 9 nm and the integration time was 1 s. The cuvette contained 1.4 ml of DNA duplex R5 (7.5 nM) in a buffer containing 50 mM sodium phosphate pH 7.0 and 50 mM NaCl. A protein mixture was titrated into the DNA solution in the cuvette and measured after a 2 min incubation.
Fluorescence anisotropy at each titration step was measured three times and averaged with relative standard deviation always lower than 3%. The values of dissociation constants were determined by non-linear least square fits according to the equation r = r MAX c/(Kd+c) using ORIGIN ® 2018 (OriginLab, Northampton, MA) and confirmed by symbolic equation-based fitting using Dynafit 48 .
Fluorescent protein labeling
Fluorescent protein labeling has been performed according to the protocol provided by the supplier with the following modifications. Alexa Fluor 488 or 594 labels (Molecular Probes -Invitrogen) in fourfold molar excess over protein were diluted in 1/10 volume of 1M sodium bicarbonate, fluorophores were mixed with protein (0.1 µg) and incubated for 1 hour at 4°C while stirring. The mixture was loaded on PD-10 columns (GE Healthcare) and eluted with 50 mM sodium phosphate pH 7, 50 mM NaCl. The protein degree of labeling higher than 85 % was confirmed by UV/Vis spectroscopy.
Microscale thermophoresis (MST) assay
MST is an in-solution method for the quantitative description of molecular interactions. MST measurements were performed with a NanoTemper Monolith NT.115 instrument (NanoTemper Technologies). Fluorescently labeled TIN2 (Alexa Fluor 488) (10 μL) was incubated for 10 min on ice with different concentrations of TRF1 or TRF2 (10 μL), in 50 mM sodium phosphate buffer pH 7.0 with 50 mM NaCl. Then, 5 μL of the samples was loaded into premium treated capillaries, and MST measurements were collected at 12 °C at 30% blue-laser power and 60% light-emitting-diode power.
The laser-on and laser-off intervals were 20 and 5s, respectively. MO.Affinity Analysis v2.2.4 software was used to fit the data and to determine apparent KD values. All measurements were collected at least three times for two independently prepared sample sets.
Theoretical Concept of FCS and FCCS
Fluorescence correlation spectroscopy (FCS) describes spontaneous fluorescence intensity fluctuations caused by rapidly diffusing molecules in a microscopic detection volume (about one femtoliter). FCS determines mobility and kinetics at single-molecule precision 33 . cross-correlation function of two-color system, with one green-labeled particle G and the second with red-labeled particle R is described as follows 
Conditions for Microscopy Imaging and Spectroscopy Measurements
All the FCCS measurements were performed with a confocal laser scanning microscope Zeiss LSM 780 using dedicated software ZEN Studio with additional FCS module. For excitation, the Ar + laser was For each experiment, raw data containing 50 repetitions of 10-second acquisition were collected and averaged. This approach ensured that we collected enough data to obtain statistically significant values.
The raw data were exported and analyzed with software QuickFit 3 50 Experimental conditions are the same as described in Figure 4 . The aggregates were formed also when TRF2 lacking the basic B-domain was used. Superdex™ 10/300 GL column with 50mM NaCl, 50mM phosphate pH 7.0 as mobile phase was used for the chromatographic separation. TRF1 and TRF2 were labeled by AlexaFluor 594 and AlexaFluor 488, respectively. Fractions corresponding to numbered peaks were collected and analyzed on SDS-PAGE. Labeled proteins in gels were detected using Typhoon™ FLA 9500 detection system. Peak 1 contains both labeled proteins within TRF1-TIN2-TPP1-TRF2 complex. Peak 2 represents TRF1-TIN2, peak 3 -TRF1, peak 4 -TRF2, peak 5 -TIN2. was measured upon addition of unlabeled TIN2 or preformed TIN2-TPP1 complex. The relative crosscorrelation corresponds to the proportion of cross-correlation amplitude related to the TRF2 autocorrelation amplitude. The low relative cross-correlation indicates no interaction between TRF1 and TRF2, hence TIN2 was insufficient to interconnect TRF1 and TRF2 into a stable complex. On the contrary, upon addition of preformed TIN2-TPP1 complex, the significant increase of relative crosscorrelation of TRF1 and TRF2 was observed. The relative cross-correlation increase demonstrates that the TRF1 and TRF2 were simultaneously diffusing through the confocal volume together. The TRF1-TIN2-TPP1-TRF2 complex was formed only if TPP1 was present. 
